Neurologic recovery of paraplegia following use of salmon calcitonin in a patient with paget’s disease of spine

Spine

Volumn 4, Issue 1, 1979, Pages 37-40

  Ravichandran, G ^a  

^a Orthopaedic Hospital   (United Kingdom)

Author keywords

Calcitonin; Laminectomy; Paget s disease; Paraplegia; Thoracic spine

Indexed keywords

CALCITONIN;

BONE; CASE REPORT; DIAGNOSIS; ETIOLOGY; LAMINECTOMY; NERVOUS SYSTEM; PAGET BONE DISEASE; PARAPLEGIA; THERAPY;

CALCITONIN; CASE REPORT; HUMAN; LAMINECTOMY; MALE; MIDDLE AGE; OSTEITIS DEFORMANS; PARAPLEGIA; REMISSION, SPONTANEOUS; SPINAL DISEASES;

EID: 0018391836     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/00007632-197901000-00006     Document Type: Article

References (35)

1. Albright F, Henneman PH: The suppression of Pa-get’s disease with ACTH and cortisone. Trans Assoc Am Physicians 68:238, 1955
2. Avramides A, Flores A, De Rose J, Wallach S: Treatment of Paget’s disease of bone with once a week injection of salmon calcitonin. Br Med J 2:632, 1975
3. Avramides A, Flores A, DeRose J, Wallach S: Paget’s disease of bone: Observations after cessation of long term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab 42(3):459-463, 1976
4. Avramides A: Salmon and porcine calcitonin treatment of Paget’s disease of bone. Clin Orthop 127:78-85, 1977
5. Cartlidge NEF, Collum JPK, Ayyar RD: Spinal cord compression in Paget’s disease. J Neurol Neurosurg Psychiatry 35:825-828, 1972
6. Christiansen C, Tonnesen KH: Zinc-protamine- glucagon in treatment of Paget’s disease of bone: Preliminary report. Acta Med Scand 196(6):495-496, 1974
7. Claus-Walker J, Spencer WA, Carter RE, Halstead LS, Meier RH, et al: Bone metabolism in quad- raplegia: Dissociation between calciuria and hydroxyprolinuria. Arch Pliys Med Rehabil 56:327-332, 1975
8. Condon JR, Reith SBM, Nassim JR, Millard FJC, Hilb A, et al: Treatment of Paget’s disease of bone with mithramycin. Br Med J 1:421-423, 1971
9. Copp DH, Cameron EC, Cheney BA, George A, Davidson F, et al: Evidence for Calcitonina new hormone from parathyroid that lowers blood calcium. Endocrinology 70:638-649, 1962
10. Curran JE: Neurological sequelae of Paget’s disease of the vertebral column and skull base. Austra- las Radiol 19:15-19, 1975
11. DeRose J, Singer FR, Avramides A, Flores A, Dziadiw R, et al: Response of Paget’s disease to porcine and salmon calcitonins—Effects of long term treatment. Am J Med 56:858-866, 1974
12. Elias G, Evans JT: Mithramycin in the treatment of Paget’s disease of bone. J Bone Joint Surg 54A(8): 1730-1736, 1972
13. Fennelly JJ, Grorke JF: Effect of Actinomycin D on Paget’s disease of bone. Br Med J 1:423-426, 1971
14. Finnerman GA, Gonick HC, Smith RK, Mayfield JM: Diphosphonate treatment of Paget’s disease. Clin Orthop 120:115-124, 1976
15. Foster GV, Doyle FH, Bordier P, Matrajit H: Effect of thyro-calcitonin on bone. Lancet 2:1428-1431, 1966
16. Goff B: Grading of spasticity and its effect on voluntary movement. Physiotherapy 62(11):358-361, 1976
17. Haddad JG, Caldwell JC: Calcitonin resistance: Clinical and immunological studies in subjects with Paget’s disease of bone treated with porcine and salmon calcitonin. J Clin Invest 51:3133-3141, 1972
18. Higgins BA, Nassim JR, Alexander R, Hilb A: Effect of sodium fluoride on calcium, phosphorous and nitrogen balance in patients with Paget’s disease. Br Med J 1:423-426, 1965
19. Hosking DJ, JavVanAken, Bijvoet OLM, Will EJ: Paget’s bone disease treated with diphosphonate and calcitonin. Lancet 1:615-618, 1976
20. Maurice PF, Lynch TN, Bastomsky CH, Dull TA, Avioli LV, et al: Metabolic evidence of suppression of Paget’s disease of bone by aspirin. Trans Assoc Am Physicians 75:208-219, 1967
21. Melick RA, Ebeling P, Hjorth RJ: Improvement in paraplegia in vertebral Paget’s disease treated by calcitonin. Br Med J 1:627-628, 1976
22. Moffatt WH, Morrow JD, Simpson N: Effects of calcitonin therapy on deafness associated with Paget’s disease of bone. Br Med J 4:203, 1974
23. Pepin B, Hubault A, Goldstein B, Bourdarias H, Lidy C: Evolution regressive sons l’effet de la Cal- citonine d’une compression medullaire pagetique. Ann Med Interne 127:243-246, 1976
24. Russell RGG, Preston C, Smith R, Walton RJ, Woods CG: Diphosphonates in Paget’s disease. Lancet 1:894-898, 1974
25. Russell AS, Lentle BC: Mithramycin therapy in Paget’s disease. Can Med Assoc J 110:397, 1974
26. Sadar ES, Walton RJ, Gossman HH: Neurological dysfunction in Paget’s disease of the vertebral column. J Neurosurg 37:661-665, 1972
27. Schmidek HH: Neurological and neurosurgical sequelae of Paget’s disease of bone. Clin Orthop 127:70-77, 1977
28. Shai F, Baker RK, Wallach S: The clinical and metabolic effect of porcine calcitonin on Paget’s disease of bone. J Clin Invest 50:1927-1940, 1971
29. Siegelman SS, Levine SA, Walpin L: Paget’s disease with spinal cord compression. Clin Radiol 19:421-425, 1968
30. Singer R: Human calcitonin treatment of Paget’s disease of bone. Clin Orthop 127:86-93, 1977
31. Smith R, Russell RG, Bishop MC, Woods CG, Bishop M: Paget’s disease of bone. Q J Med 166:235, 1973
32. Somerville PJ, Evans RA: Actinomycin D in the treatment of Paget’s disease of bone. Med J Aust 2(1): 13-16, 1975
33. Woodhouse NJY, Bordier PH, Fisher M, Joplin GF, Reiner M, et al: Human calcitonin in the treatment of Paget’s bone disease. Lancet l: 1139-1143, 1971
34. Woodhouse NJY, MacIntyre I, Joplin GF, Doyle FH: Radiological regression in Paget’s disease treated by human calcitonin. Lancet 2:992-994, 1972
35. Woodhouse NJY: Clinical applications of calcitonin. Br J Hosp Med 677-684, 1974